Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | ||||||||||
| Cash paid | -17.70%-1.16M | -5.00%-987.76K | -36.43%-940.71K | 16.16%-689.51K | -126.30%-822.42K | 21.49%-363.43K | 49.09%-462.9K | -24.20%-909.2K | -143.98%-732.03K | 41.29%-300.04K |
| Payments to suppliers for goods and services | -17.70%-1.16M | -5.00%-987.76K | -36.43%-940.71K | 16.16%-689.51K | -126.30%-822.42K | 21.49%-363.43K | 49.09%-462.9K | -24.20%-909.2K | -348.09%-732.03K | 40.88%-163.37K |
| Other cash payments from operating activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 41.77%-136.67K |
| Direct interest received | -76.04%6.18K | 878.31%25.8K | -53.55%2.64K | 33.92%5.68K | 781.29%4.24K | -49.79%481 | -49.23%958 | -71.22%1.89K | 526.27%6.56K | -80.18%1.05K |
| Operating cash flow | -20.21%-1.16M | -2.55%-961.96K | -37.18%-938.08K | 16.42%-683.84K | -125.43%-818.19K | 21.43%-362.95K | 49.09%-461.94K | -25.06%-907.31K | -142.64%-725.48K | 38.78%-298.99K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -77.79%-963.85K | 23.43%-542.13K | 34.00%-708.06K | -153.47%-1.07M | 75.58%-423.23K | -665.11%-1.73M | 46.11%-226.56K | -13.33%-420.44K | -924.58%-371K | 44.99K |
| Capital expenditure reported | -61.63%-553K | 51.68%-342.13K | 34.00%-708.06K | -59.92%-1.07M | -500.05%-670.83K | 50.65%-111.79K | 16.82%-226.56K | -13.54%-272.37K | ---239.88K | ---- |
| Net PPE purchase and sale | -105.42%-410.85K | ---200K | ---- | ---- | --247.59K | ---- | ---- | ---21.87K | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---1.41M | ---- | 3.75%-126.2K | ---131.11K | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --44.99K |
| Net other investing changes | ---- | ---- | ---- | ---- | 218.15%250K | ---211.59K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -77.79%-963.85K | 23.43%-542.13K | 34.00%-708.06K | -153.47%-1.07M | 75.58%-423.23K | -665.11%-1.73M | 46.11%-226.56K | -13.33%-420.44K | -924.58%-371K | --44.99K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 115.19%4.06M | -1.45%1.89M | 378.71%1.91M | -85.16%399.91K | 15.22%2.69M | 397.88%2.34M | -60.34%469.63K | -17.84%1.18M | 1,799.14%1.44M | 75.9K |
| Net issuance payments of debt | -150.00%-250K | -263.82%-100K | 113.23%61.04K | -266.71%-461.39K | ---125.82K | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | 116.94%4.31M | 7.19%1.99M | 115.18%1.85M | -69.46%861.3K | 20.60%2.82M | 397.88%2.34M | -60.34%469.63K | -17.84%1.18M | 1,799.14%1.44M | --75.9K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 115.19%4.06M | -1.45%1.89M | 378.71%1.91M | -85.16%399.91K | 15.22%2.69M | 397.88%2.34M | -60.34%469.63K | -17.84%1.18M | 1,799.14%1.44M | --75.9K |
| Net cash flow | ||||||||||
| Beginning cash position | 49.66%1.15M | 53.45%770.12K | -73.00%501.86K | 357.83%1.86M | 147.40%405.96K | -57.15%164.09K | -27.38%382.95K | 189.15%527.35K | -49.44%182.38K | -57.55%360.75K |
| Current changes in cash | 407.09%1.94M | 42.58%382.47K | 119.77%268.25K | -193.40%-1.36M | 500.58%1.45M | 210.51%241.87K | -52.52%-218.86K | -141.60%-143.5K | 293.70%344.97K | 63.53%-178.1K |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---908 | ---- | 61.63%-269 |
| End cash Position | 168.27%3.09M | 49.66%1.15M | 53.45%770.12K | -73.00%501.86K | 357.83%1.86M | 147.40%405.96K | -57.15%164.09K | -27.38%382.95K | 189.15%527.35K | -49.44%182.38K |
| Free cash from | -70.16%-2.56M | 8.63%-1.5M | 6.29%-1.65M | -17.78%-1.76M | -214.15%-1.49M | 31.05%-474.74K | 42.70%-688.49K | -24.47%-1.2M | -222.88%-965.36K | 38.78%-298.99K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |